Predicine, a precision medicine company based in Silicon Valley, announced today that the company has entered into a global strategic partnership with Suzhou Kintor Pharmaceuticals to increase the speed and efficiency of biomarker-driven global clinical trials for Kintor’s novel oncology drugs and the development of companion diagnostics for FDA and CFDA approvals. Kintor will leverage...
Predicine is Exhibiting at AACR 2024 from April 5-10 with 14 Posters Featured!